Lyt til Pharma and BioTech Daily podcast

Eli Lilly's Retatrutide: 22.6% Weight Loss in Phase 3! \| Pharma and Biotech Daily	Pharma and BioTech Daily	04:34
Repligen Buys BioLife for $1.5B \| Pharma and Biotech Daily	Pharma and BioTech Daily	05:06
Bristol Myers & NVIDIA's $1.5B AI Deal: Game Changer? \| Pharma and Biotech Daily	Pharma and BioTech Daily	04:52
Samsung Biologics' $1.8B Peptide Expansion \| Pharma and Biotech Daily	Pharma and BioTech Daily	05:36
Jasper Merges with Kira for $292M \| Pharma and Biotech Daily	Pharma and BioTech Daily	05:19
Merck's $5B Lipfendra FDA Approval Revolutionizes Cholesterol \| Pharma and Biotech Daily	Pharma and BioTech Daily	04:46
Veradermics' $2B Hair Loss Market Move with Oral Minoxidil \| Pharma and Biotech Daily	Pharma and BioTech Daily	05:48
Biogen's $1.5B Deal & FDA Approval for Alzheimer's Drug \| Pharma and Biotech Daily	Pharma and BioTech Daily	04:35
Pfizer & Merck's $3B Bladder Cancer Breakthrough \| Pharma and Biotech Daily	Pharma and BioTech Daily	04:57
Sanofi's FDA Approval: $160M Boost for Sarclisa in Cancer Care \| Pharma and Biotech Daily	Pharma and BioTech Daily	05:16
Ipsen's Dysport Hits Phase 3 Milestone vs. Botox \| Pharma and Biotech Daily	Pharma and BioTech Daily	05:13
Vera Therapeutics' Trutakna Gets FDA Nod for IgA Nephropathy \| Pharma and Biotech Daily	Pharma and BioTech Daily	04:34
Vertex Acquires Crinetics for $10B \| Pharma and Biotech Daily	Pharma and BioTech Daily	04:45
Novartis' $1.1B Myricx Acquisition Boosts ADC Pipeline \| Pharma and Biotech Daily	Pharma and BioTech Daily	05:12
FDA Accelerated Approval: New Drug for Breast Cancer \| Pharma and Biotech Daily	Pharma and BioTech Daily	04:43
Roche's Divarasib Surpasses Amgen in Trials \| Pharma and Biotech Daily	Pharma and BioTech Daily	05:26
Orca Bio's Tregzi Wins FDA Approval for GVHD \| Pharma and Biotech Daily	Pharma and BioTech Daily	05:27
FDA Fast-Tracks Eli Lilly & Regeneron \| Pharma and Biotech Daily	Pharma and BioTech Daily	04:41
Ipsen Buys Kartos for $1.75B \| Pharma and Biotech Daily	Pharma and BioTech Daily	05:24
Replimune's RP1 Resubmission to FDA: Will It Finally Pass? \| Pharma and Biotech Daily	Pharma and BioTech Daily	05:11
Merck's $11.3B Bio-Techne Acquisition \| Pharma and Biotech Daily	Pharma and BioTech Daily	04:52
Eli Lilly's $1.9B Abbisko Partnership Boosts Cancer R&D \| Pharma and Biotech Daily	Pharma and BioTech Daily	05:08
Carsgen's $2T Satricabtagene Approval Milestone \| Pharma and Biotech Daily	Pharma and BioTech Daily	05:14
Carsgen's CAR-T Breakthrough in China for Solid Tumors \| Pharma and Biotech Daily	Pharma and BioTech Daily	04:39
FDA Approves Alzheimer's Drug Amid Debate \| Pharma and Biotech Daily	Pharma and BioTech Daily	04:14
FDA Approves Utebzi, Biogen Acquires Raythera for $1B \| Pharma and Biotech Daily	Pharma and BioTech Daily	04:51
Eli Lilly's $65B M&A Surge & FDA's Drug Import Approval \| Pharma and Biotech Daily	Pharma and BioTech Daily	05:19
Intellia's 89% Success in Phase 3 CRISPR Trial \| Pharma and Biotech Daily	Pharma and BioTech Daily	03:54
Novartis' $23M RNA Breakthrough & Tavneos FDA Battle \| Pharma and Biotech Daily	Pharma and BioTech Daily	05:19
Takeda's Zasocitinib Beats Sotyktu in Phase 3 Trial \| Pharma and Biotech Daily	Pharma and BioTech Daily	05:03
Pfizer CEO Rethinks Germany Investments Amid Reform Concerns \| Pharma and Biotech Daily	Pharma and BioTech Daily	04:58
Merck & Gilead's HIV Pill Breakthrough: Phase 3 Success! \| Pharma and Biotech Daily	Pharma and BioTech Daily	05:23
Eli Lilly's Retatrutide Breakthrough: 30.3% Weight Loss Success \| Pharma and Biotech Daily	Pharma and BioTech Daily	04:35
Pfizer & Chai AI Breakthrough: $1.675B Gilead Deal \| Pharma and Biotech Daily	Pharma and BioTech Daily	04:31
Eli Lilly & Boehringer Cut $1B+ Investments in Germany \| Pharma and Biotech Daily	Pharma and BioTech Daily	05:11
Legend Biotech's CAR T-Cell Breakthrough: 100% Response Rate \| Pharma and Biotech Daily	Pharma and BioTech Daily	05:50
Moderna-Merck Combo Cuts Melanoma Risk by 49% \| Pharma and Biotech Daily	Pharma and BioTech Daily	05:15
Akeso's Ivonescimab Shows 34% Death Risk Cut at ASCO \| Pharma and Biotech Daily	Pharma and BioTech Daily	05:26
Pfizer's $10B Innovent Deal Boosts Cancer Drugs \| Pharma and Biotech Daily	Pharma and BioTech Daily	05:20
Eli Lilly's Zepbound Coverage Restored! Breaking News \| Pharma and Biotech Daily	Pharma and BioTech Daily	05:43

Eli Lilly's Retatrutide: 22.6% Weight Loss in Phase 3! | Pharma and Biotech Daily

Pharma and BioTech Daily

04:34

Repligen Buys BioLife for $1.5B | Pharma and Biotech Daily

Pharma and BioTech Daily

05:06

Bristol Myers & NVIDIA's $1.5B AI Deal: Game Changer? | Pharma and Biotech Daily

Pharma and BioTech Daily

04:52

Samsung Biologics' $1.8B Peptide Expansion | Pharma and Biotech Daily

Pharma and BioTech Daily

05:36